ARG1 and cancer: Thus, even if using the blockade of immune checkpoints could mask the inhibitory receptor activation of T cells, the hostile local immunosuppressive TME created by TAMs-derived factors (i.e., arginase-1 (Arg1) and interleukin-10) directly reduces the cytotoxicity of T cells against cancer cells [11].